Researchers sought to evaluate the role of insulin administration method on glycemic control, hypoglycemia risk, treatment adherence, and quality of life in older adults with type 2 diabetes. To ...
Study design. This prospective, randomized, controlled, parallel-group study compared the use of pen devices with conventional vials and syringes for the administration of insulin in hospitalized ...
The US Food and Drug Administration (FDA) has cleared the Bigfoot Unity Diabetes Management System, a cap device that connects to insulin pens and translates continuous glucose data into dosing ...
PORTLAND, Ore. (KOIN) — A recall has been issued for insulin pens from one manufacturer because they may not have labels on the injectors, the Food and Drug Administration said in a press release ...
In a significant step forward, Bigfoot Biomedical got the greenlight from the Food and Drug Administration for its “smart” insulin pen cap, developed to be paired with a continuous glucose monitor. It ...
The Food and Drug Administration has approved Novo Nordisk’s prefilled insulin pens called the NovoLog ® FlexTouch ® and Levemir ® FlexTouch ®. FlexTouch ® pens’ dosing mechanism ensures the ...
Credit: Getty Images. The recall does not pertain to the interchangeable biosimilars, Semglee (insulin glargine-yfgn) injection, or Insulin Glargine (insulin glargine-yfgn) injection. Mylan ...
Mylan Pharmaceuticals has recalled some insulin-glargine injection pens because they may be missing labels. According to an announcement with the U.S. Food and Drug Administration, the lack of a label ...
(RTTNews) - Mylan Pharmaceuticals Inc., affiliated to healthcare company Viatris Inc., is recalling certain Insulin Glargine (Insulin glargine-yfgn) Injection prefilled pens due to the potential for ...
Rising Diabetes Rates and Digital InnovatioFuel European Insulin Pen Market Growth European Insulin Pen Market European ...
Rising Diabetes Drives Technological Advancements in North America Insulin Pen Market: Shift to Self-Care and Home-Based ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback